| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | GAINS Positioned as the Leader in the 2026 SPARK Matrix for Supply Chain Network Design (SCND) by QKS Group | 193 | PR Newswire | The QKS Group SPARK Matrix provides competitive analysis and ranking of the leading Supply Chain Network Design vendors.GAINS, with its comprehensive technology for SCND, has received strong... ► Artikel lesen | |
| 16.05. | Scientific Industries, Inc.: Scientific Industries Reports First Quarter Fiscal 2026 Results | 444 | ACCESS Newswire | REVENUES UP 30%OPERATING EXPENSES DOWN 12%SUCCESSFUL LAUNCH OF EXPANDED VIVID SUBSCRIPTION PLANS BOHEMIA, NY / ACCESS Newswire / May 15, 2026 / Scientific Industries, Inc. (OTCQB:SCND), a developer... ► Artikel lesen | |
| SCIENTIFIC INDUSTRIES Aktie jetzt für 0€ handeln | |||||
| 01.04. | Scientific Industries GAAP EPS of -$0.11, revenue of $5.1M | 1 | Seeking Alpha | ||
| 01.04. | Scientific Industries, Inc.: Scientific Industries Reports Financial Results for Fiscal Year Ended December 31, 2025 | 730 | ACCESS Newswire | TORBAL DIVISION SALES UP 20%SECOND GENERATION VIVID-ONE LAUNCH SCHEDULED FOR CY26BIOPROCESSING DIVISION DOTS PLATFORM CONTINUES TO EXPAND WITH AI LEARNING PLATFORM FOR BIOMANUFACTURING BOHEMIA, NY /... ► Artikel lesen | |
| 31.03. | SCIENTIFIC INDUSTRIES INC - 10-K, Annual Report | - | SEC Filings | ||
| 20.01. | Scientific Industries bestellt nach Akquisition neuen Wirtschaftsprüfer | 2 | Investing.com Deutsch | ||
| 20.01. | SCIENTIFIC INDUSTRIES INC - 8-K, Current Report | 1 | SEC Filings | ||
| 20.11.25 | Scientific Industries, Inc.: Scientific Industries Announces Third Quarter 2025 Results And Launch of VIVID's New AI-Powered Feature | 400 | GlobeNewswire (Europe) | TORBAL DIVISION SALES UP 15% YTDLAUNCH OF VIVID'S FIRST AI-POWERED FEATURESECOND GENERATION VIVID-ONE LAUNCH SCHEDULED FOR Q1 CY26 Investor Call to be held Thursday, November 20th at 11:00 a.m. Eastern... ► Artikel lesen | |
| 19.08.25 | Scientific Industries, Inc.: Scientific Industries Reports Financial Results for Second Quarter of Fiscal Year 2025 | 196 | GlobeNewswire (Europe) | TORBAL DIVISION SALES UP 11%SECURED $10 MILLION IN STRATEGIC DIVESTURE OF GENIE PRODUCT LINEVIVID AND BIOPROCESSING NEW PRODUCT AI ROADMAP ON TARGET Investor Call to be held Wednesday, August 20th... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 37,260 | +1,61 % | DAX-Verlierer: Die fünf Verlierer des Monats im DAX - Diese Werte enttäuschten | © Foto: Julian Stratenschulte/dpa Der Mai 2026 brachte für Anleger Höhenflüge und Abstürze. Ein Überblick über die fünf schwächsten Aktien im DAX.Während einige DAX-Werte im Mai deutliche Kursgewinne... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,37 | -0,05 % | BrightSpring Health Services, Inc. - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 34,840 | +0,55 % | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,180 | +1,17 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC mit einem Kursziel von 37 Euro auf "Sell" belassen. Anstehende Daten eines Konkurrenzprodukts könnten das Potenzial für optimistischere... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 15,380 | +0,07 % | Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year | ||
| GENEDX | 52,26 | +0,10 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| BILLIONTOONE | 97,20 | +0,01 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROGYNY | 25,850 | -0,04 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| ONCOLOGY INSTITUTE | 4,870 | 0,00 % | Oncology Institute, Inc. - 8-K, Current Report | ||
| CARL ZEISS MEDITEC | 26,740 | +0,38 % | Aktien - Shortseller-Positionen: Carl Zeiss Meditec, Evotec, HelloFresh, Kontron, LPKF Laser, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| VIVOS THERAPEUTICS | 0,856 | -1,04 % | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing | LITTLETON, Colo., June 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,850 | +0,07 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| UNITEDHEALTH | 346,20 | -0,17 % | UnitedHealth: "Kaufen" - startet die Aktie jetzt durch? | Die Aktie von UnitedHealth könnte nach Einschätzung der Bank of America vor einer weiteren Aufwärtsbewegung stehen. Die Analysten haben ihre Einstufung für den US-Krankenversicherer von "Neutral" auf... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 9,360 | +0,11 % | Alpha Tau Medical Ltd.: Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting | - Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of... ► Artikel lesen | |
| HEARTFLOW | 28,110 | +0,04 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen |